ʻO nā kumukūʻai maikaʻi maikaʻi e kūʻai aku ai i ka uku kālā ma mua o 50% cas: 501-36-0

1: Hiki i ke pale i ka hoʻohemoʻana o ka pale umauma, he maʻi koloheʻo Christmasodod.
2. E hōʻemi i nā lāʻau carriovascular, e hōʻemi i ka lipid lipid, a hikiʻole iā ia ke pale i ka maʻi naʻau, akāʻo ia ka hopena o nā maʻi anti-AID.
3.ʻO Antioxidant, me ka anti-inflamortory, anti-thrombus, anti-cancer, Anti-canperlitidemia nui, anti-canperlipidemia nui, anti-canperlipidemia nui.
4. E hoʻolōʻihi i ka huhū, hoʻoponopono i nā lipids koko, pale i ka cardionvascular a me cerebrovascular, a hakakāʻo ia he hepatitis
5 Loaʻa kahi phytolic phytantitoxin i nāʻili a me nā mea kanu'ē aʻe i loaʻa i ka hana antracellular a me ka hana o sirt1; He inoa inoaʻo Nad + -deperan i loaʻa i keʻano o ka biochemichicket ʻO ka Annidiabtic, NeuroProtective, a me Adi Speaking of Resetratratrol e hoʻolahaʻia e SRT1ʻO ka hoʻouluʻana
6.cox-1 ceastive inhibitor. Resvetratrol is is phenolic phytlic phytonintinitin i loaʻa i nāʻili i nāʻili a me nā mea kanu'ē aʻe. Ua loaʻa iā Antracellular Anteracellar i hana i ka hana empicalbook e hana i ka sert1. ʻO ka Annidiabtic, NeuroProtective, a me nā waiwai antlipid o ka restiteratrol e hana paha ma muli o ka hoʻouluʻana o ka sirst1.